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Objective: The purpose of this study was to investigate the relationship between the prostatic urethral
angle (PUA) and the peak urinary ﬂow rate (Qmax), as well as the severity of lower urinary tract symp-
toms (LUTS) in men with benign prostate hyperplasia.
Materials and methods: The records of ﬁrst-visit male patients with LUTS in the outpatient department of
our institution were obtained. A transrectal ultrasound was performed on these patients after a detailed
physical examination and medical history taking were performed. The International Prostate Symptom
Score (IPSS) of the patients, the prostate size, the length of intravesical prostatic protrusion (IPP), and the
PUA were evaluated. The patients also underwent uroﬂowmetry and bladder scan for residual urine.
Results: A total of 227 patients were included in this study. The mean PUA was 44.58 ± 12.87. The mean
prostate volume was 39.39 ± 19.79 mL, and the mean IPP was 4.82 ± 6.82 mm. After utilizing multi-
variate linear regression analysis, PUA was independently associated with IPSS (p < 0.001) and Qmax
(p < 0.001). However, prostate volume and IPP were not associated with the above clinical items. None of
the prostatic parameters were associated with the amount of postvoiding residual urine.
Conclusion: PUA has a remarkable correlation with Qmax and IPSS in men with LUTS. As PUA increased,
IPSS also increased, and urinary ﬂow rate decreased, exhibiting an inverse relationship.
Copyright © 2014, Taiwan Urological Association. Published by Elsevier Taiwan LLC. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Benign prostatic hyperplasia is a major cause of lower urinary
tract symptoms (LUTS) in males, and it affects about 210 million
people worldwide.1 However, the fact that prostate size has no
remarkable associationwith the severity of the symptoms has been
reported in several studies2,3 There are some other anatomic factors
that have also been considered as possible factors affecting the
severity of the symptoms, for example, transitional zone index and
the intravesical prostatic protrusion (IPP).4e6 Kuo7 also established
a clinical prostate score by using the simple parameters of uro-
ﬂowmetry and transrectal ultrasonography (TRUS) measurements
that can conveniently diagnose benign prostate obstruction of male
LUTS with a good sensitivity and speciﬁcity. Recently, the prostatic
urethral angle (PUA) has been regarded as a possible factorang Gung Memorial Hospital,
Taiwan.
ociation. Published by Elsevier Taaffecting male LUTS.8 As demonstrated by Cho et al,9 the prostatic
urethra is a bent-formed tube, and the kinetic energy of the voiding
urine would decrease because of the angle during micturition. The
greater the angle, the greater the amount of kinetic energy that
would be lost.9 A mathematical simulation has been created to
demonstrate the relationship between the urinary ﬂow rate and
PUA.8 The equation is as follows:
Q ¼ pd
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where d represents the prostatic urethra diameter, p represents the
vesical pressure, Q is the urine ﬂow rate, and q is the PUA. As shown
in the equation, the greater the angle of q, the lower Q beco-
mesdthat is, the urinary ﬂow rate is inversely associated with PUA.
However, this hypothesis, which is based on mathematical simu-
lation, requires further clinical observation in order to be
conﬁrmed. The purpose of our study was to clarify the inﬂuence ofiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
Fig. 1. The relationship between the prostatic urethral angle (PUA) and the length of
intravesical prostatic protrusion (IPP). (A) PUA is deﬁned as the angle formed by the
proximal prostate urethra and distal prostate urethral. (B) IPP is measured from the tip
of the protruding prostate into the bladder to the bladder circumference at the prostate
base in the sagittal plane.
Table 1
Characteristics of the patients (n ¼ 227).
Characteristics Mean ± SD (range)
Age (y) 65.88 ± 9.49 (45e89)
BMI 24.91 ± 3.12 (43.22e18.21)
IPSS
Total 17.05 ± 4.54 (9e26)
Voiding symptoms 9.25 ± 3.73 (4e19)
Storage symptoms 7.78 ± 2.21 (3e13)
Uroﬂowmetry
Qmax (mL/s) 7.47 ± 2.60 (2e16)
Voiding volume (mL) 222.41 ± 66.35 (114e453)
Residual urine (mL) 32.40 ± 37.62 (0e381)
TRUS
TPV (mL) 39.39 ± 19.79 (12.42e133.01)
PUA () 44.58 ± 12.87 (24e87)
IPP (mm) 4.82 ± 6.82 (0e31.31)
BMI¼ body mass index; IPP ¼ intravesical prostate protrusion; IPSS ¼ International
Prostate Symptom Score; PUA ¼ prostatic urethral angle; Qmax ¼ peak ﬂow rate;
SD ¼ standard deviation; TPV ¼ total prostate volume; TRUS ¼ transrectal
ultrasonography.
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amount of postvoid residual urine.
2. Materials and methods
From October 2012 to February 2014, the records of ﬁrst-visit
male patients with LUTS who agreed to undergo TRUS and uro-
ﬂowmetry prior to receiving treatment in our institution were
obtained. These patients underwent a detailed medical history
taking and physical examination. They were excluded if they had
any evidence of neurologic disorder that could affect voiding
function, uncontrolled diabetes mellitus, or any malignant disease.
Those found to have a history of prostate surgery, presenting with
indwelling urinary catheter, having dementia or any disability that
could interfere with verbal communication were excluded as well.
Patients who had already taken alpha blockers were also excluded.
All the chosen participants were verbally informed of the purpose
and the entire procedure involved in performing TRUS, uro-
ﬂowmetry study, and International Prostate Symptom Score (IPSS)
evaluation. A total of 227 patients were included in the study.
A transrectal ultrasound was performed on these patients by a
single urologist using a single ultrasound machine (SSD-A6,
ALOKA), with a 7.5-MHz biplanar transrectal probe. All patients in
our study had a full bladder when undergoing TRUS examination.
The ellipse formula (length  width  height  0.52) was used to
measure the size of the prostate volume. PUA, as illustrated in
Fig. 1A, was deﬁned as the angle formed by the proximal prostate
urethra and distal prostate urethra, as suggested by Cho et al.8 IPP,
as illustrated in Fig.1B, wasmeasured from the tip of the protruding
prostate into the bladder to the bladder circumference at the
prostate base in the sagittal plane, as suggested by Nose et al.10
The IPSS11 of the patients were also recorded by a single quali-
ﬁed urologist during the medical history taking. Uroﬂowmetry and
a bladder scan for the postvoiding residual urine were performed
on every patient. TheManneWhitney test was used to compare the
PUA according to IPSS and Qmax. Multivariate linear regression
analysis was performed to analyze the independent association of
the patients' parameters with Qmax, IPSS scores, and the postvoid-
ing residual urine. SPSS version 15.0 (SPSS, Inc., Chicago, IL, USA)
was applied for statistical analysis. All statistical tests were con-
ducted with a signiﬁcance level of p ¼ 0.05.
3. Results
The subject characteristics of the patients are summarized in
Table 1. A total of 227 patients were included in our study. The
mean age of the patients was 65.88 ± 9.49 years. The mean total
prostate volume was 39.39 ± 19.79 mL, and the mean PUA was
44.58 ± 12.87. The mean IPSS, mean Qmax, mean voiding volume,
and mean postvoiding residual urine volumewere 17.05 ± 4.54 mL,
7.47 ± 2.60 mL/second, 222.41 ± 66.35 mL, and 32.40 ± 37.62 mL,
respectively.
Table 2 outlines a comparison of PUA and IPP according to IPSS.
We can see that themean PUA of the patients whose IPSS scores are
 20 is 40.83, whereas that of patients whose IPSS scores are > 20
is 55.95. There are signiﬁcant differences between the two groups
(p < 0.001). Meanwhile, the mean IPP of patients whose IPSS scores
are 20 is 3.99 mm, whereas that of patients whose IPSS scores are
 20 is 7.05 mm. There are signiﬁcant differences between the two
groups as well (p < 0.001). Table 3 shows a comparison of PUA and
IPP according toQmax.We can see that the mean PUA of the patients
whose Qmax are < 10 mL/second is 45.28, whereas that of patients
whose Qmax  10 is 41.18 (p ¼ 0.016). There are signiﬁcant differ-
ences between the two groups. Meanwhile, the mean IPP of the
patients whose Qmax are < 10 mL/second is 5.15 mm, whereas that
Table 2
Comparison of PUA and IPP according to IPSS.
IPSS  20
n ¼ 173
IPSS > 20
n ¼ 54
p
Mean PUA () 40.83 55.95 < 0.001a
Mean IPP (mm) 3.99 7.05 0.012a
IPP ¼ intravesical prostate protrusion; PUA ¼ prostatic urethral angle;
IPSS ¼ International Prostate Symptom Score.
a ManneWhitney test.
Table 4
Relationship between prostatic parameters and IPSS.
IPSS IPSSv IPSSs
Variable t ratio p t ratio p t ratio p
Age 0.228 0.820 0.523 0.601 0.300 0.765
BMI 0.517 0.606 0.640 0.523 0.021 0.983
TPV 0.835 0.143 4.554 0.035a 1.548 0.123
PUA 10.822 <0.001a 11.535 <0.001a 2.840 0.005a
IPP 0.543 0.543 0.923 0.357 2.072 0.039a
BMI¼ bodymass index; IPP¼ intravesical prostate protrusion; IPSSv¼ International
Prostate Symptom Score, voiding; IPSSs ¼ International Prostate Symptom Score,
storage; PUA ¼ prostatic urethral angle; TPV ¼ total prostate volume.
a Multivariate linear regression analysis.
Table 5
Relationship between prostatic parameters and Qmax.
Variable t ratio p
Age 0.561 0.576
BMI 1.057 0.292
TPV 0.505 0.614
PUA 7.572 <0.001a
IPP 1.404 0.162
BMI ¼ body mass index; IPP ¼ intravesical prostate protrusion; PUA ¼ prostatic
urethral angle; Qmax ¼ peak ﬂow rate; TPV ¼ total prostate volume.
a Multivariate linear regression analysis.
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indicates that there is no signiﬁcant difference between the two
groups.
Table 4 reveals the relationship between IPSS and the inde-
pendent prostatic parameters. We ﬁnd that PUA has a very strong
correlation with IPSS, whether regarding total scores (p < 0.001),
voiding symptom scores (p < 0.001), or storage symptom scores
(p ¼ 0.005). Although total prostate volume has no remarkable
correlation with IPSS total scores (p ¼ 0.143) and storage symptom
score (p ¼ 0.123), there was a slightly signiﬁcant association with
voiding symptom score (p ¼ 0.035). However, other parameters,
such as age, body mass index, or IPP, had no correlation with IPSS,
although IPP had only a slightly signiﬁcant associationwith storage
symptom score (p ¼ 0.039). Table 5 highlights the relationship
between Qmax and the independent prostatic parameters. We ﬁnd
that PUA has a negative correlation with Qmax (p < 0.001), whereas
the other parameters do not. Table 6 demonstrates the relationship
between postvoiding residual urine and prostatic parameters. This
table shows that none of the parameters are associated with the
postvoiding residual urine.4. Discussion
TRUS is an accurate study that can be carried out at an outpa-
tient clinic to evaluate the anatomical structure of the prostate.12
The prostatic urethra can be seen clearly on the sagittal view. It
runs through the prostate from the base to the apex, at an angle
involving the proximal part of the verumontanum. This angle is
deﬁned as the PUA.13 An increased PUA may be the result of a high
bladder neck, which is suspected as a clinically signiﬁcant causal
factor of male LUTS.8
Because there are many factors other than prostate that may
affect voiding, patient selection is very important with regard to
this study. To avoid other factors that may inﬂuence our study, we
excluded the patients who had any neurologic disorder that could
affect voiding function, uncontrolled diabetes mellitus, or any
malignant disease. Those who had taken alpha blockers, had a
history of prostate surgery, or presented with indwelling urinary
catheter were also excluded.
The results of our study can explain the clinical ﬁndings that the
severity of LUTS and the urinary ﬂow rate are not relative to
prostate size. On the contrary, PUA plays a very important role. In
our study, PUA has a signiﬁcant associationwith IPSS and Qmax. ThisTable 3
Comparison of PUA and IPP according to Qmax.
Qmax < 10 mL/s
n ¼ 173
Qmax  10 mL/s
n ¼ 54
p
Mean PUA () 45.28 41.18 0.016a
Mean IPP (mm) 5.15 3.33 0.159
IPP ¼ intravesical prostate protrusion; IPSS ¼ International Prostate Symptom
Score; PUA ¼ prostatic urethral angle; Qmax ¼ peak ﬂow rate.
a ManneWhitney test.clinical ﬁnding is compatible with that of the previous related
literature. A study by Bang et al14 demonstrated that PUA has strong
relationship with Qmax and IPSS in men with LUTS. Ku et al13 found
that PUA correlates with the bladder outlet obstruction (BOO) in-
dex. In other words, as PUA increases, the severity of BOO also
increases.13
IPP has been regarded as another possible prostatic parameter
associated with voiding function. Chia et al15 suggests that IPP
causes a “ball-valve” type of obstruction. It disrupts the funneling
effect of the bladder neck, causing dyskinesia of the bladder during
voiding. The IPP is a more reliable predictor of BOO than the
prostate volume, and a greater IPP was associated with a higher
BOO index.15 According to Table 2, the mean IPP of the patients
whose IPSS scores are < 20 is smaller than that of patients whose
IPSS scores are > 20 (p ¼ 0.012). It seems that IPP has relationship
with IPSS. However, to avoid any statistical pitfalls and to make the
study more precise, we further investigated the relationship be-
tween IPP and IPSS by means of multivariate linear regression
analysis. Soon afterward, we found that IPP has no linear correla-
tion with either IPSS (p ¼ 0.543) or Qmax (p ¼ 0.162), as shown in
Tables 4 and 5. Our study result is different from that reported
previously by other scholars. One possible reason for this might be
that the mean IPP of our patients is only 4.82 mm. However, the
study by Keqin et al16 showed that the impact on the BOO will be
signiﬁcant only when the IPP is > 10 mm. Therefore, most of our
patients' IPP are too short to reveal the correlation between IPSS
and Qmax.Table 6
Relationship between prostatic parameters and postvoid residual urine.
Variable t ratio p
Age 1.011 0.313
BMI 1.262 0.208
TPV 0.188 0.851
PUA 0.254 0.799
IPP 1.846 0.066
BMI ¼ body mass index; IPP ¼ intravesical prostate protrusion; PUA ¼ prostatic
urethral angle; TPV ¼ total prostate volume.
a Multivariate linear regression analysis.
C.-P. Hou et al. / Urological Science 27 (2016) 47e5050This study has a number of limitations that should be high-
lighted. First of all, the PUA is measured at resting status, and not at
voiding status. In fact, prostatic urethral anatomy can be altered
during micturition, and PUA may not reﬂect the anatomy of the
prostatic urethra during voiding.17 Second, to evaluate the severity
of BOO, pressure-ﬂow examination measured by urodynamic in-
vestigations is a more accurate method,18 although it is an un-
pleasant examination for the patients to undergo. Using
uroﬂowmetry and bladder scan alone to evaluate the patients'
voiding function might make the accuracy questionable. However,
we believe that our study results are still valid. According to the
study of Kuo et al, video-pressure-ﬂow study is not necessary for
every patient when evaluating their BOO. On the contrary, patients
with LUTS can be diagnosed with a good sensitivity and speciﬁcity
by combining uroﬂowmetry and TRUS.7 We intend to make this
current study an ongoing study. Thus, our future aim will be to
focus on recruiting more patients, investigating how PUA in-
ﬂuences the treatment efﬁcacy of alpha blockers, and probing
whether 5-alpha reductase inhibitors alter a patients' PUA after the
treatment.5. Conclusion
The results of our study reveal that as the PUA is increased, the
patient's voiding symptoms worsened, and the urinary ﬂow rate
decreased, exhibiting an inverse relationship. The urinary ﬂow rate
and the severity of LUTS in men with benign prostatic hyperplasia
are signiﬁcantly affected by PUA, but not by prostate volume.Conﬂicts of interest
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